Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people feel the effects of Wegovy within hours of their first injection. The most commonly reported early reactions are nausea, stomach discomfort and fatigue, and trial data show these tend to be most pronounced in the first few days after starting or increasing a dose. According to the NHS semaglutide medicines guide, gastrointestinal symptoms are the side effects reported most frequently, and they are generally mild to moderate. Because Wegovy is a prescription-only medicine, a prescriber assesses your individual health picture before treatment begins — the early side-effect profile is part of that conversation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 clinical trial, published in the New England Journal of Medicine, enrolled nearly 2,000 adults and followed them for 68 weeks on semaglutide 2.4mg. Gastrointestinal events were the leading category of adverse reactions, and the pattern in the data is consistent: they cluster around dose initiations and increases, then ease off as the body adapts. Nausea was the single most reported event, followed by vomiting and diarrhoea.
What the trial cannot fully capture is the subjective texture of that first injection day. In clinical experience, some people feel a faint queasiness within a few hours, roughly the time it takes semaglutide to begin slowing gastric emptying. Others notice nothing at all for the first 24 hours. There is genuine individual variation, and that variation is not a sign that the medicine is working better or worse.
The timing matters practically too. Many people choose a Friday evening injection so that any first-day grogginess falls over a weekend rather than a working morning. If your routine makes that impossible, having a light meal beforehand can help. These small adjustments are worth raising during your consultation rather than working out alone afterwards.
Nausea tends to be the earliest sensation, sometimes accompanied by a reduced appetite that feels more sudden than expected. Burping and reflux are common too, if persistent burping is troubling you, our detailed guide on burping with Wegovy explains what drives it and how most people manage it. Loose stools or diarrhoea can start within the first couple of days for some people, though constipation is equally possible and sometimes alternates with looser bowels in the early weeks.
Fatigue is reported by a meaningful proportion of people starting treatment, not dramatic exhaustion, but the kind of tiredness that makes an early night seem more appealing. Headache and dizziness appear in the data too, usually mild and brief. Injection-site redness, itching or a small lump at the injection point is possible but typically resolves within a day or two.
The overall side-effect picture for men can differ slightly in how symptoms present; the specific profile for men on Wegovy covers those distinctions. And a notable group of people, explored in the no-side-effects guide, experience very little in the early phase at all, this is not unusual and is not a reason to assume the medicine is inactive.
Most early reactions are uncomfortable rather than dangerous, but some symptoms need same-day or emergency medical attention. The MHRA's Yellow Card scheme exists so that patients and clinicians can report suspected adverse reactions, including serious ones, and the MHRA issued a Drug Safety Update in January 2026 specifically flagging acute pancreatitis as a known, infrequent but potentially serious reaction to GLP-1 medicines.
Contact your GP or call 111 if you develop severe, persistent stomach pain that radiates towards your back, with or without vomiting. That symptom pattern needs assessment for pancreatitis. Gallbladder symptoms (sharp pain in the upper right abdomen, particularly after eating) also warrant prompt review. Signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, or a widespread rash) are an emergency: call 999.
Significant dehydration from prolonged vomiting or diarrhoea is a risk worth taking seriously. If you cannot keep fluids down for more than 24 hours, contact a healthcare professional rather than waiting it out. A full overview of the side-effect landscape across the whole treatment course is available in the Wegovy side effects guide, which also covers what tends to improve over time and what to monitor longer term.
Practical steps help. Eating smaller portions at mealtimes rather than one large meal reduces the likelihood of nausea after injection. Staying well hydrated (plain water throughout the day, not just alongside meals) supports both comfort and safety. Avoiding rich, fatty or very spicy food in the first week is a straightforward move that many people find genuinely useful; it does not need to be a strict dietary overhaul.
The timing of the injection relative to meals is less critical than many people assume, Wegovy can be taken at any time of day regardless of food, unlike the oral semaglutide tablet. What does matter is rotating your injection site (thigh, abdomen, upper arm) and following the storage guidance in your patient information leaflet to keep the pen effective. If you have questions about how the medicine works more broadly, the Wegovy treatment overview covers the mechanism and the licensed uses in more depth.
The titration schedule (starting at a low dose and increasing gradually over several months) is not administrative caution. It is the clinical mechanism for reducing early side-effect severity, and the data from STEP 1 support it. Trying to speed through the schedule is one of the patterns that leads to avoidable discomfort. Our prescribers at nume discuss how the schedule works, and what to expect at each stage, as part of the consultation, you can start that conversation here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.